TSX:HHL Holdings Information

TSX:HHL is an equity ETF with a total of 24 individual holdings. The top holdings are Eli Lilly and Company stock at 5.21%, Bristol-Myers Squibb Company at 5.16%, Amgen at 5.14%, Thermo Fisher Scientific at 5.08%, and Agilent Technologies at 5.08%.

Total Holdings

Top 10 Percentage

50.89%

Asset Class

Equity

ETF Category

Health Care

Assets

1.62B

PE Ratio

20.72

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	5.21%	74,301
2	BMY	Bristol-Myers Squibb Company	5.16%	1,378,781
3	AMGN	Amgen Inc.	5.14%	211,863
4	TMO	Thermo Fisher Scientific Inc.	5.08%	110,171
5	A	Agilent Technologies, Inc.	5.08%	426,743
6	NVSN.MX	Novartis AG ADR	5.07%	503,743
7	MRK	Merck & Co., Inc.	5.05%	722,656
8	AZN	AstraZeneca PLC	5.05%	753,941
9	JNJ	Johnson & Johnson	5.05%	328,891
10	DHR	Danaher Corporation	5.01%	286,407
11	BSX	Boston Scientific Corporation	5.00%	611,330
12	ZTS	Zoetis Inc.	4.99%	425,958
13	ISRG	Intuitive Surgical, Inc.	4.98%	114,801
14	MDT	Medtronic plc	4.97%	674,600
15	UNH	UnitedHealth Group Incorporated	4.96%	178,616
16	ABT	Abbott Laboratories	4.95%	492,936
17	REGN	Regeneron Pharmaceuticals, Inc.	4.94%	93,317
18	ELV	Elevance Health, Inc.	4.80%	186,355
19	ABBV	AbbVie Inc.	4.79%	270,535
20	SYK	Stryker Corporation	4.33%	149,494
21	n/a	Harvest Canadian T Bill Etp	0.93%	321,834
22	n/a	Cash And Other Net Assets And Liabilities	0.45%	n/a
23	n/a	Foreign Currency Forwards	-0.36%	n/a
24	n/a	Written Call Options	-0.63%	n/a

As of Oct 31, 2025